Johansson B, Mertens F, Mitelman F
Department of Clinical Genetics, Lund University Hospital, Sweden.
Genes Chromosomes Cancer. 1991 Jan;3(1):1-7. doi: 10.1002/gcc.2870030102.
Using a database comprising 13,266 cytogenetically abnormal neoplasms, the geographic heterogeneity of neoplasia-associated chromosomal abnormalities was investigated by comparing the frequencies of characteristic aberrations in consecutive series of patients with the same diagnosis. Significant frequency differences between geographic areas were found for the aberrations +8, i(17q), +19, and an additional Ph1 chromosome in chronic myeloid leukemia (CML); -5, 5q-, and +8 in acute nonlymphocytic leukemia (ANLL); t(8;21) in ANLL-M2; t(15;17) in ANLL-M3; 5q- and -7 in myelodysplastic syndromes (MDS); t(9;22) and +21 in acute lymphocytic leukemia (ALL); t(14;18) in follicular lymphoma; -8 and -22/22q- in meningioma; and structural abnormalities of 12q in pleomorphic adenoma of the salivary glands (PAS). No geographic incidence variation was detected for -7 and +21 in ANLL; +8 in MDS; 6q- and +8 in ALL; +12 in chronic lymphocytic leukemia; 6q- in non-Hodgkin's lymphoma (NHL); t(8;14) in Burkitt's lymphoma; t(11;22) in Ewing's sarcoma; i(12p) in germ cell tumors; 1p- in neuroblastoma; structural abnormalities of 3q, 8q, and 9p in PAS; or 3p- in renal cell carcinoma. Intraregional frequency similarities between cytogenetically identical abnormalities in related tumor types were also analyzed. No significant correlations were found regarding the incidence of 5q- in ANLL and MDS, 6q- in ALL and NHL, -7 in ANLL and MDS, +8 in ANLL and CML, +8 in ANLL and MDS, +8 in ALL and ANLL, or +21 in ALL and ANLL. The findings indicate that some geographic heterogeneity of tumor-associated aberrations exists both in hematologic neoplasms and in solid tumors.(ABSTRACT TRUNCATED AT 250 WORDS)
利用一个包含13266例细胞遗传学异常肿瘤的数据库,通过比较同一诊断的连续系列患者中特征性畸变的频率,研究了肿瘤相关染色体异常的地理异质性。在慢性髓性白血病(CML)中,发现+8、i(17q)、+19以及额外的Ph1染色体畸变在不同地理区域的频率存在显著差异;在急性非淋巴细胞白血病(ANLL)中,-5、5q-和+8存在显著差异;在ANLL-M2中,t(8;21)存在显著差异;在ANLL-M3中,t(15;17)存在显著差异;在骨髓增生异常综合征(MDS)中,5q-和-7存在显著差异;在急性淋巴细胞白血病(ALL)中,t(9;22)和+21存在显著差异;在滤泡性淋巴瘤中,t(14;18)存在显著差异;在脑膜瘤中,-8和-22/22q-存在显著差异;在涎腺多形性腺瘤(PAS)中,12q的结构异常存在显著差异。未检测到ANLL中的-7和+21、MDS中的+8、ALL中的6q-和+8、慢性淋巴细胞白血病中的+12、非霍奇金淋巴瘤(NHL)中的6q-、伯基特淋巴瘤中的t(8;14)、尤因肉瘤中的t(11;22)、生殖细胞肿瘤中的i(12p)、神经母细胞瘤中的1p-、PAS中的3q、8q和9p的结构异常或肾细胞癌中的3p-存在地理发病率差异。还分析了相关肿瘤类型中细胞遗传学相同异常的区域内频率相似性。未发现ANLL和MDS中5q-的发病率、ALL和NHL中6q-的发病率、ANLL和MDS中-7的发病率、ANLL和CML中+8的发病率、ANLL和MDS中+8的发病率、ALL和ANLL中+8的发病率或ALL和ANLL中+21的发病率之间存在显著相关性。研究结果表明,肿瘤相关畸变的一些地理异质性在血液系统肿瘤和实体瘤中均存在。(摘要截取自250字)